Showing results (121-130 of 135) with videos related to
Sort By:
Pageof 14
Scientific Reports|October 24, 2020
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective studyAlberto Farolfi, Emanuela Scarpi, Filippo Greco, et al.Targeted Oncology|June 28, 2018
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)Alberto Farolfi, Micaela Petrone, Emanuela Scarpi, et al.Cancers|January 21, 2022
Beyond BRCA1/2: Homologous Recombination Repair Genetic Profile in a Large Cohort of Apulian Ovarian CancersAntonella Turchiano, Daria Carmela Loconte, Rosalba De Nola, et al.Infectious Agents and Cancer|October 22, 2022
Lactobacillus crispatus M247 oral administration: Is it really an effective strategy in the management of papillomavirus-infected women?Miriam Dellino, Eliano Cascardi, Antonio Simone Laganà, et al.Gynecologic Oncology|March 25, 2023
Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trialLucia Musacchio, Margherita Turinetto, Laura Arenare, et al.Frontiers in Oncology|October 2, 2023
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitorsFrancesca Arezzo, Gaia Giannone, Daniele Castaldo, et al.Frontiers in Oncology|February 6, 2024
Corrigendum: Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitorsFrancesca Arezzo, Gaia Giannone, Daniele Castaldo, et al.Genes|October 23, 2021
Formalin-Fixed and Paraffin-Embedded Samples for Next Generation Sequencing: Problems and SolutionsGerardo Cazzato, Concetta Caporusso, Francesca Arezzo, et al.Gynecologic Oncology|October 9, 2016
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19)Claudia Marchetti, Gabriella Ferrandina, Gennaro Cormio, et al.Cancers|September 10, 2021
Urological Melanoma: A Comprehensive Review of a Rare Subclass of Mucosal Melanoma with Emphasis on Differential Diagnosis and Therapeutic ApproachesGerardo Cazzato, Anna Colagrande, Antonietta Cimmino, et al.Pageof 14